News linked to both this project and an event.
Odaily AI-driven anti-fraud infrastructure provider InfoHawk has announced the completion of a $2.25 million Pre-Seed funding round, led by Moonshots Capital, with participation from former U.S. Federal Trade Commission Chairman Jon Leibowitz, AppNexus founder Brian O'Kelley, former Meta advertising executive Rob Goldman, GitHub CTO Vlad Fedorov, and others. The new funds will be used to support the company's application of AI content recognition and deep infrastructure analysis technology to help enterprises detect, analyze, and combat large-scale online fraud, phishing sites, brand impersonation, and Deepfake attacks. (PRNewswire)
: NewLimit, a longevity technology startup co-founded by Coinbase founder Brian Armstrong, announced the completion of a $435 million Series C funding round, achieving a valuation of $3.1 billion. The round was led by Peter Thiel's fund, Founders Fund, with continued participation from Abstract Ventures, Kleiner Perkins, NFDG, Eli Lilly Ventures, Valor Equity Partners, and others. New investors introduced in this round include Thrive Capital, Greenoaks, and Quiet Capital.In 2021, Brian Armstrong, along with former GV partner and bioengineer Blake Byers and stem cell biologist Jacob Kimmel, jointly invested $110 million to establish NewLimit in South San Francisco.
According to Tech in Asia, Special, an AI-powered M&A firm co-founded by Nate Cavanaugh and Justin Fox—both former staff members of the U.S. government’s Department of Government Efficiency (DOGE)—has announced a funding round of undisclosed amount, led by Andreessen Horowitz (a16z). Investors include Antonio Gracias, founder of Valor Equity Partners; Anthony Armstrong, former CFO of xAI; Brian Armstrong, CEO of Coinbase Global; and Shyam Sankar, CTO of Palantir Technologies. Special plans to acquire service-based businesses by automating workflows with AI to reduce costs, and has already reached an agreement to acquire a Texas-based healthcare company, which will be integrated into Figure Health—the company’s business line focused on aging populations.